Oncoprint of mutations co-occurring with PTPN11 mutations and PTPN11 mutation VAFs in patients with AML. Each column represents an individual patient. The top row represents PTPN11 VAFs, ranging from 0.05 (blue) to 0.54 (yellow). Each subsequent row represents a gene. Green squares indicate the presence of a mutation, insertion, or deletion; gray squares represent no alteration detected; and white squares represent unavailable gene alteration status.